Katayama, Akihiro
Tone, Atsuhito
Watanabe, Mayu
Teshigawara, Sanae
Miyamoto, Satoshi
Eguchi, Jun
Nakatsuka, Atsuko
Shikata, Kenichi
Wada, Jun
Article History
Received: 25 June 2019
Accepted: 10 September 2019
First Online: 16 September 2019
Compliance with ethical standards
:
: Author Atsuhito T. received lecture fees from Medtronic Japan, Sanofi and Eli Lilly. Author Jun W. received lecture fees from Astellas, Astra Zeneca, Boeringer Ingelheim Japan, Daiichi Sankyo, MSD, Novartis, Tanabe Mitsubishi and Taisho Toyama, and received research funding from Bayer, Baxter, Chugai, Dainippon Sumitomo, Kyowa Hakko Kirin, MSD, Novartis, Novo Nordisk, Ono, Takeda, Tanabe Mitsubishi and Teijin. Other authors declare that they have no conflict of interest associated with this research.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. This study was approved by the ethics committee of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (approval no: ken1812-016, approval date: 14 December 2018). We did not receive the informed consent, but we provided the participants with the opportunity to deny by publishing the Opt Out document.